Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of tadalafil versus PRP on cavernosal inflammatory markers in vasculogenic erectile dysfunction
PACTR202506917694681Phase 2Completed
- Sponsor
- Ahmed M. Elattar
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tadalafil and platelet-rich plasma in Vascular Erectile Dysfunction (3 arms), sponsored by Ahmed M. Elattar. Primary endpoint: Change in cavernosal C-reactive protein and fibrinogen levels. Started Mar 2023; status: completed.
02
Drugs
tadalafilplatelet-rich plasma
03
Conditions
Vascular Erectile Dysfunction
Beyond the preview
Go deeper on PACTR202506917694681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506917694681.